Bifidobacteria can protect from enteropathogenic infection through production of acetate - PubMed (original) (raw)
. 2011 Jan 27;469(7331):543-7.
doi: 10.1038/nature09646.
Hidehiro Toh, Koji Hase, Kenshiro Oshima, Yumiko Nakanishi, Kazutoshi Yoshimura, Toru Tobe, Julie M Clarke, David L Topping, Tohru Suzuki, Todd D Taylor, Kikuji Itoh, Jun Kikuchi, Hidetoshi Morita, Masahira Hattori, Hiroshi Ohno
Affiliations
- PMID: 21270894
- DOI: 10.1038/nature09646
Bifidobacteria can protect from enteropathogenic infection through production of acetate
Shinji Fukuda et al. Nature. 2011.
Abstract
The human gut is colonized with a wide variety of microorganisms, including species, such as those belonging to the bacterial genus Bifidobacterium, that have beneficial effects on human physiology and pathology. Among the most distinctive benefits of bifidobacteria are modulation of host defence responses and protection against infectious diseases. Nevertheless, the molecular mechanisms underlying these effects have barely been elucidated. To investigate these mechanisms, we used mice associated with certain bifidobacterial strains and a simplified model of lethal infection with enterohaemorrhagic Escherichia coli O157:H7, together with an integrated 'omics' approach. Here we show that genes encoding an ATP-binding-cassette-type carbohydrate transporter present in certain bifidobacteria contribute to protecting mice against death induced by E. coli O157:H7. We found that this effect can be attributed, at least in part, to increased production of acetate and that translocation of the E. coli O157:H7 Shiga toxin from the gut lumen to the blood was inhibited. We propose that acetate produced by protective bifidobacteria improves intestinal defence mediated by epithelial cells and thereby protects the host against lethal infection.
Similar articles
- Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters.
Fukuda S, Toh H, Taylor TD, Ohno H, Hattori M. Fukuda S, et al. Gut Microbes. 2012 Sep-Oct;3(5):449-54. doi: 10.4161/gmic.21214. Epub 2012 Jul 24. Gut Microbes. 2012. PMID: 22825494 Review. - Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
Yoshimura K, Matsui T, Itoh K. Yoshimura K, et al. Antonie Van Leeuwenhoek. 2010 Feb;97(2):107-17. doi: 10.1007/s10482-009-9391-y. Epub 2009 Nov 13. Antonie Van Leeuwenhoek. 2010. PMID: 19911297 - Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.
Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y. Asahara T, et al. Infect Immun. 2004 Apr;72(4):2240-7. doi: 10.1128/IAI.72.4.2240-2247.2004. Infect Immun. 2004. PMID: 15039348 Free PMC article. - Protective effects of bifidobacteria against enteropathogens.
Aw W, Fukuda S. Aw W, et al. Microb Biotechnol. 2019 Nov;12(6):1097-1100. doi: 10.1111/1751-7915.13460. Epub 2019 Jul 8. Microb Biotechnol. 2019. PMID: 31284329 Free PMC article. - A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.
Nawrocki EM, Mosso HM, Dudley EG. Nawrocki EM, et al. Appl Environ Microbiol. 2020 Nov 24;86(24):e00509-20. doi: 10.1128/AEM.00509-20. Print 2020 Nov 24. Appl Environ Microbiol. 2020. PMID: 32358004 Free PMC article. Review.
Cited by
- The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal.
Engevik MA, Danhof HA, Hall A, Engevik KA, Horvath TD, Haidacher SJ, Hoch KM, Endres BT, Bajaj M, Garey KW, Britton RA, Spinler JK, Haag AM, Versalovic J. Engevik MA, et al. BMC Microbiol. 2021 May 24;21(1):154. doi: 10.1186/s12866-021-02166-6. BMC Microbiol. 2021. PMID: 34030655 Free PMC article. - Effects of the Food Manufacturing Chain on the Viability and Functionality of Bifidobacterium animalis through Simulated Gastrointestinal Conditions.
Charnchai P, Jantama SS, Prasitpuriprecha C, Kanchanatawee S, Jantama K. Charnchai P, et al. PLoS One. 2016 Jun 22;11(6):e0157958. doi: 10.1371/journal.pone.0157958. eCollection 2016. PLoS One. 2016. PMID: 27333286 Free PMC article. - Intestinal barrier function in health and gastrointestinal disease.
Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Camilleri M, et al. Neurogastroenterol Motil. 2012 Jun;24(6):503-12. doi: 10.1111/j.1365-2982.2012.01921.x. Neurogastroenterol Motil. 2012. PMID: 22583600 Free PMC article. Review. - Heat-Killed Lactobacillus brevis Enhances Phagocytic Activity and Generates Immune-Stimulatory Effects through Activating the TAK1 Pathway.
Jeong M, Kim JH, Lee JS, Kang SD, Shim S, Jung MY, Yang H, Byun S, Lee KW. Jeong M, et al. J Microbiol Biotechnol. 2020 Sep 28;30(9):1395-1403. doi: 10.4014/jmb.2002.02004. J Microbiol Biotechnol. 2020. PMID: 32627755 Free PMC article. - Importance of gut microbiota in health and diseases of new born infants.
Gao J, Wu H, Liu J. Gao J, et al. Exp Ther Med. 2016 Jul;12(1):28-32. doi: 10.3892/etm.2016.3253. Epub 2016 Apr 11. Exp Ther Med. 2016. PMID: 27347013 Free PMC article.
References
- J Biol Chem. 2007 Jun 22;282(25):18532-18541 - PubMed
- Biosci Biotechnol Biochem. 2002 Nov;66(11):2362-6 - PubMed
- J Mol Microbiol Biotechnol. 2007;12(1-2):9-19 - PubMed
- Nature. 1998 Jun 25;393(6687):790-3 - PubMed
- Aliment Pharmacol Ther. 2005 Sep 15;22(6):495-512 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials